A successful treatment for amyotrophic lateral sclerosis (ALS) could be worth billions, a new report suggests.  New research commission by Challenge Works and undertaken by the Office of Health Economics (OHE) estimates that a successful treatment for ALS, the most common form of motor neurone disease (MND), could be worth billions. If advances in detection […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!